ARC-2-001

N/A

Report date: 2025/01/26 16:49:08
NME

Base Information

Drug NameARC-2-001
Drug Alias NameARC-2-001
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionFibroblast inhibitors
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSungkyunkwan University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A